Published in Ann Nucl Med on December 01, 2006
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol (2009) 0.97
Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) (2013) 0.87
Chronic cholecystitis with hilar bile duct stricture mimicking gallbladder carcinoma on positron emission tomography: A case report. Mol Clin Oncol (2013) 0.84
Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer. Nucl Med Mol Imaging (2013) 0.84
Xanthogranulomatous cholecystitis mimicking gallbladder cancer. BMJ Case Rep (2014) 0.80
Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a case. Int Surg (2013) 0.79
Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis. World J Gastroenterol (2015) 0.75
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med (2008) 2.65
Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg (2002) 2.00
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA (2004) 1.78
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology (2013) 1.73
Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Am J Gastroenterol (2005) 1.72
Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Clin Cancer Res (2005) 1.64
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci (2004) 1.48
Risk factor analysis in patients with liver cirrhosis undergoing cardiovascular operations. Ann Thorac Surg (2010) 1.48
Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol (2002) 1.42
Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci (2003) 1.36
Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc (2013) 1.27
Outcomes of hepatic resection for hepatolithiasis. Am J Surg (2009) 1.26
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Ann Nucl Med (2004) 1.25
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Laparoscopic excision of a retroperitoneal cystic lymphangioma: report of a case. Surg Today (2003) 1.13
Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol (2007) 1.12
Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays. Hepatol Res (2003) 1.11
Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage (2003) 1.09
Surgical management of cystic hepatic neoplasms. J Gastroenterol (2003) 1.08
Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence. Hepatol Res (2005) 1.07
Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol (2009) 1.05
Eosinophilic enteritis presenting as acute intestinal obstruction: a case report and review of the literature. Dig Surg (2003) 1.05
Effectiveness of preoperative PET examination of huge angiosarcoma of the heart. Clin Nucl Med (2009) 1.05
Asymptomatic thrombosis as a late complication of a retrohepatic vena caval graft performed for primary leiomyosarcoma of the inferior vena cava: report of a case. Surg Today (2002) 1.04
Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma. Intervirology (2005) 1.04
Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World J Surg (2004) 1.04
A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET. Ann Nucl Med (2005) 1.00
Predictive factors for surgical indication in adhesive small bowel obstruction. Am J Surg (2008) 0.99
Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2005) 0.99
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study. J Gastroenterol (2014) 0.98
A case of hepatic inflammatory pseudotumor identified by FDG-PET. Ann Nucl Med (2006) 0.98
Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol (2006) 0.98
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med (2005) 0.98
FDG uptake by tongue and muscles of mastication reflecting increased metabolic activity of muscles after chewing gum. Clin Nucl Med (2003) 0.97
p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology (2004) 0.97
Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med (2003) 0.95
CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. Hepatogastroenterology (2004) 0.95
Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg (2008) 0.94
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res (2006) 0.94
Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients. World J Gastroenterol (2008) 0.94
NEC density and liver ROI S/N ratio for image quality control of whole-body FDG-PET scans: comparison with visual assessment. Mol Imaging Biol (2009) 0.94
Self-expanding metallic stent for benign biliary strictures: seven-year follow-up. Hepatogastroenterology (2004) 0.94
The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer (2013) 0.94
Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation. Liver Transpl (2013) 0.94
Lymphoscintigraphy with single-photon emission computed tomography/computed tomography is useful for determining the site of chyle leakage after esophagectomy. Indian J Nucl Med (2012) 0.93
Splenic accumulation of Tc-99m HMDP in a patient with severe alcoholic cirrhosis of the liver. Clin Nucl Med (2005) 0.93
Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. J Surg Res (2002) 0.93
Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2014) 0.93
Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial. Hepatol Res (2003) 0.93
Nutritional risk index as an independent predictive factor for the development of surgical site infection after pancreaticoduodenectomy. Surg Today (2012) 0.93
Surgical strategy for hepatocellular carcinoma originating in the caudate lobe. Surgery (2004) 0.93
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences. J Med Virol (2007) 0.92
Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. J Nucl Med (2003) 0.92
Disease associations and altered immune function in CD45 138G variant carriers. Hum Mol Genet (2004) 0.92
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology (2014) 0.92
Pseudotumor of the omentum with a fishbone nucleus. J Gastroenterol Hepatol (2007) 0.91
Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus. J Med Virol (2009) 0.90
A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2008) 0.90
Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. J Hepatobiliary Pancreat Sci (2012) 0.90
Percutaneous transhepatic metallic stent placement for malignant portal vein stenosis. Hepatogastroenterology (2003) 0.90
Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy. Hepatol Res (2010) 0.90
Intracystic hemorrhage with spontaneous rupture of liver cyst complicated by infection: a case report. Osaka City Med J (2003) 0.89
HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol (2003) 0.89
Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res (2013) 0.88
Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. J Gastroenterol (2003) 0.88
Ureterocolic fistula detected on bone scintigraphy. Indian J Gastroenterol (2004) 0.88
Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma. Dig Surg (2005) 0.88
Plummer-Vinson syndrome successfully treated by endoscopic dilatation. J Gastroenterol Hepatol (2007) 0.88